Extract from the Register of European Patents

EP About this file: EP2047845

EP2047845 - ADHESIVE PREPARATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.08.2020
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  06.09.2019
FormerGrant of patent is intended
Status updated on  17.03.2019
FormerExamination is in progress
Status updated on  04.08.2017
Most recent event   Tooltip10.06.2022Lapse of the patent in a contracting state
New state(s): CY, MT
published on 13.07.2022  [2022/28]
Applicant(s)For all designated states
Hisamitsu Pharmaceutical Co., Inc.
408, Tashirodaikan-machi
Tosu-shi, Saga 841-0017 / JP
[2009/16]
Inventor(s)01 / TSURUDA, Kiyomi
HISAMITSU PHARMACEUTICAL CO., INC.
408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
02 / YAMASOTO, Shinji
HISAMITSU PHARMACEUTICAL CO., INC.
408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
03 / SHOHO, Kouki
HISAMITSU PHARMACEUTICAL CO., INC.
408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
04 / NAKANISHI, Masaru
Tsukuba Laboratory
of HISAMITSU PHARMACEUTICAL CO., INC.
25-11, Kannondai 1-chome
Tsukuba-shi Ibaraki 305-0856 / JP
 [2019/41]
Former [2009/16]01 / TSURUDA, Kiyomi
HISAMITSU PHARMACEUTICAL CO., INC. 408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
02 / YAMASOTO, Shinji
HISAMITSU PHARMACEUTICAL CO., INC. 408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
03 / SHOHO, Kouki
HISAMITSU PHARMACEUTICAL CO., INC. 408, Tashirodaikan-machi
Tosu-shi Saga 841-0017 / JP
04 / NAKANISHI, Masaru
Tsukuba Laboratory of HISAMITSU PHARMACEUTICAL CO., INC. 25-11, Kannondai 1-chome
Tsukuba-shi Ibaraki 305-0856 / JP
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2019/41]
Former [2009/16]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Application number, filing date07791748.201.08.2007
[2009/16]
WO2007JP65067
Priority number, dateJP2006021367004.08.2006         Original published format: JP 2006213670
[2009/16]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008016077
Date:07.02.2008
Language:JA
[2008/06]
Type: A1 Application with search report 
No.:EP2047845
Date:15.04.2009
Language:EN
[2009/16]
Type: B1 Patent specification 
No.:EP2047845
Date:09.10.2019
Language:EN
[2019/41]
Search report(s)International search report - published on:JP07.02.2008
(Supplementary) European search report - dispatched on:EP02.10.2013
ClassificationIPC:A61K9/70, A61K31/045, A61K31/618, A61K47/10, A61K47/34, A61K47/46, A61P25/02, A61P29/00, A61P43/00
[2009/16]
CPC:
A61K9/7053 (EP,US); A61K9/70 (KR); A61L15/44 (US);
A61K31/045 (EP,KR,US); A61K31/618 (EP,KR,US); A61K31/695 (EP,US);
A61K9/7076 (EP,US); A61L15/24 (US); A61L15/58 (US);
A61P17/02 (EP); A61P25/02 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61F13/00 (US);
A61F15/00 (US); A61L2300/216 (US); B32B7/12 (US);
Y10T428/28 (EP,US); Y10T428/2852 (EP,US); Y10T442/2738 (EP,US);
Y10T442/3561 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/41]
Former [2009/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL06.11.2008
BA06.11.2008
HR06.11.2008
MK06.11.2008
RS06.11.2008
TitleGerman:KLEBSTOFFPRÄPARAT[2009/16]
English:ADHESIVE PREPARATION[2009/16]
French:PRÉPARATION ADHÉSIVE[2009/16]
Entry into regional phase06.11.2008Translation filed 
06.11.2008National basic fee paid 
06.11.2008Search fee paid 
06.11.2008Designation fee(s) paid 
06.11.2008Examination fee paid 
Examination procedure12.05.2008Request for preliminary examination filed
International Preliminary Examining Authority: JP
06.11.2008Examination requested  [2009/16]
05.12.2013Amendment by applicant (claims and/or description)
22.01.2016Despatch of a communication from the examining division (Time limit: M04)
31.03.2016Reply to a communication from the examining division
25.07.2017Despatch of a communication from the examining division (Time limit: M04)
22.11.2017Reply to a communication from the examining division
18.03.2019Communication of intention to grant the patent
10.07.2019Fee for grant paid
10.07.2019Fee for publishing/printing paid
10.07.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.01.2016
Opposition(s)10.07.2020No opposition filed within time limit [2020/38]
Fees paidRenewal fee
28.08.2009Renewal fee patent year 03
27.08.2010Renewal fee patent year 04
30.08.2011Renewal fee patent year 05
30.08.2012Renewal fee patent year 06
28.08.2013Renewal fee patent year 07
27.08.2014Renewal fee patent year 08
26.08.2015Renewal fee patent year 09
29.08.2016Renewal fee patent year 10
29.08.2017Renewal fee patent year 11
28.08.2018Renewal fee patent year 12
27.08.2019Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.10.2019
CY09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
MT09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
TR09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
[2022/27]
Former [2022/26]AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
TR09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2021/18]AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
MC09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/51]AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
SI09.10.2019
SK09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/37]AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
SK09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/36]AT09.10.2019
CZ09.10.2019
DK09.10.2019
EE09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
BG09.01.2020
GR10.01.2020
IS09.02.2020
PT10.02.2020
Former [2020/35]AT09.10.2019
CZ09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
RO09.10.2019
SE09.10.2019
BG09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/24]AT09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
GR10.01.2020
PT10.02.2020
IS24.02.2020
Former [2020/23]AT09.10.2019
FI09.10.2019
LT09.10.2019
LV09.10.2019
NL09.10.2019
PL09.10.2019
SE09.10.2019
BG09.01.2020
GR10.01.2020
PT10.02.2020
Former [2020/22]FI09.10.2019
LT09.10.2019
NL09.10.2019
SE09.10.2019
BG09.01.2020
PT10.02.2020
Former [2020/20]NL09.10.2019
Documents cited:Search[Y] EP1284138  (HISAMITSU PHARMACEUTICAL CO et al.) [Y] 1-10 * example 6 * * paragraph [0017] - paragraph [0020] *
 [Y] EP1238664  (HISAMITSU PHARMACEUTICAL CO et al.) [Y] 1-10 * examples 5, 6,10 *
 [Y] GB2045618  (HISAMITSU PHARMACEUTICAL CO et al.) [Y] 1-10 * examples 1,2 *
 [Y] EP1676895  (HISAMITSU PHARMACEUTICAL CO et al.) [Y] 1-10 * examples 1-12 *
International search[X] JP2006045101  (LINTEC CORP et al.) [X]
 [Y] JP2003169823  (LION CORP et al.) [Y]
 [Y] JPH07265353  (LECTEC CORP et al.) [Y]
 [Y] JPS54143517  (HISAMITSU PHARMACEUTICAL CO) [Y]
 [Y] JPS63222113  (KAO CORP et al.) [Y]
 [Y] JPH0457872  (BANDO CHEMICAL IND et al.) [Y]
 [XP] JP2007015963  (HISAMITSU PHARMACEUTICAL CO et al.) [XP]
 [YP] JP2007151916  (HISAMITSU PHARMACEUTICAL CO et al.) [YP]
 [Y]   MARTIN D. ET AL.: "Dermal absorption of camphor, methanol, and methyl salicylate in humans", J. CLIN. PHARMACOL., vol. 44, no. 10, 2004, pages 1151 - 1157, XP003020898 [Y]

DOI:   http://dx.doi.org/10.1177/0091270004268409
 [Y]   USAMI E.: "Methyl Salicylate o Shuseibun to suru Shippuzai no Sayo no Hikaku Kento: Comparison study of the action of femontation, with methyl salicylate as the main component", NIPPON BYOIN YAKUZAISHIKAI ZASSHI, vol. 29, no. 9, 1993, pages 1003 - 1008, XP003020899 [Y]
 [Y]   MIYAZAKI M.: "Kakushu Seikei Cataplasms no Yakkogakuteki Hyoka", SYMPOSIUM DAI 3 KAI KEIHI KYUSHUGATA SEIZAI SYMPOSIUM POSTER SESSION 14, THERAPEUTIC RESEARCH, vol. 8, no. 1, 1988, pages 257 - 258, XP003020900 [Y]
 [Y]   MIYAZAKI M.: "Seikei Cataplasms no Yakuzaigakuteki Kento", BYOIN YAKUGAKU, vol. 14, no. 3, 1988, pages 192 - 197, XP003021001 [Y]
 [Y]   VALDEZ J.S. ET AL.: "Sensitive and selective gas chromatography methods fo the quantitation of camphor, menthol and methyl salicylate from human plasma", J. CHROMATOGR. B. BIOMED. SCI. APPL., vol. 729, no. 1-2, 1999, pages 163 - 171, XP004170445 [Y]

DOI:   http://dx.doi.org/10.1016/S0378-4347(99)00161-9
 [Y]   TSUBOI M.: "Seikei Cataplasms no Kiso Gaiyo Tenkazai ni yoru Hifu Seibutsu Kassei no Henka to Cataplasms no Shuyaku (Salicylic Acid Ester-rui) no Keihi Kyushu ni tsuite", SYMPOSIUM DAI 1 KAI KEIHI KYUSHUGATA SEIZAI SYMPOSIUM, THERAPEUTIC RESEARCH, vol. 3, no. 6, 1985, pages 987 - 993, XP003021002 [Y]
by applicant  "Biomedical sciences and applications", JOURNAL OF CHROMATOGRAPHY. B, vol. 729, no. 1-2, 11 June 1999 (1999-06-11), pages 163 - 71
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.